Gut microbiota composition in patients with Crohn’s disease in Saudi Arabia
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0299749 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Hadil Alahdal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Crohn Disease, Gastrointestinal Microbiome, RNA, Ribosomal, 16S. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Princess Nourah Bint Abdulrahman University.
Abstract (Originalsprache)
Crohn’s disease (CD) entails intricate interactions with gut microbiome diversity, richness, and composition. The relationship between CD and gut microbiome is not clearly understood and has not been previously characterized in Saudi Arabia. We performed statistical analysis about various factors influencing CD activity and microbiota dysbiosis, including diagnosis, treatment, and its impact on their quality of life as well as high-throughput metagenomic V3-V4 16S rRNA encoding gene hypervariable region of a total of eighty patients with CD, both in its active and inactive state with healthy controls. The results were correlated with the demographic and lifestyle information, which the participants provided via a questionnaire. α-diversity measures indicated lower bacterial diversity and richness in the active and inactive CD groups compared to the control group. Greater dysbiosis was observed in the active CD patients compared to the inactive form of the disease, showed by a reduction in microbial diversity. Specific pathogenic bacteria such as Filifactor , Peptoniphilus , and Sellimonas were identified as characteristic of CD groups. In contrast, anti-inflammatory bacteria like Defluviitalea , Papillibacter , and Petroclostridium were associated with the control group. Among the various factors influencing disease activity and microbiota dysbiosis, smoking emerged as the most significant, with reduced α-diversity and richness for the smokers in all groups, and proinflammatory Fusobacteria was more present ( p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biology, Faculty of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
- Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
- Biostatistics Section, King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
- King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
- Artificial Intelligence and Bioinformatics Department, King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
- Department of Health Informatics, College of Public Health and Health Informatics, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
ORCID-Profile: Hadil Alahdal, Abdulrahman Aljouie
Förderung
- Princess Nourah Bint Abdulrahman University
Zitieren
APA
Alahdal, H., Almuneef, G., Alkhulaifi, M. M., Aldibasi, O., Aljouie, A., Alharbi, O., Almohawes, Z. N., Basingab, F., & Rejili, M. (2024). Gut microbiota composition in patients with Crohn’s disease in Saudi Arabia. PLOS ONE. https://doi.org/10.1371/journal.pone.0299749
Vancouver
Alahdal H, Almuneef G, Alkhulaifi MM, Aldibasi O, Aljouie A, Alharbi O, et al. Gut microbiota composition in patients with Crohn’s disease in Saudi Arabia. PLOS ONE. 2024. doi:10.1371/journal.pone.0299749
BibTeX
@article{Alahdal2024,
author = {Alahdal, Hadil and Almuneef, Ghaida and Alkhulaifi, Manal Muhammed and Aldibasi, Omar and Aljouie, Abdulrahman and Alharbi, Othman and Almohawes, Zakiah Naser and Basingab, Fatemah and Rejili, Mokhtar},
title = {Gut microbiota composition in patients with Crohn’s disease in Saudi Arabia},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0299749}
}
EUVIMED